{
    "SPADE_UN_12168": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_12168",
            "Peptide Name": "Val-nHSLP",
            "Source": "Synthetic construct",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "WWVXARAXRR",
            "Sequence Length": 10,
            "UniProt Entry": "No entry found",
            "Protein Existence": "Synthetic form",
            "Biological Activity": [
                "Antimicrobial",
                "Antibacterial",
                "Anti-Gram+",
                "Anti-Gram-"
            ],
            "Target Organism": "[Ref.28073163] Gram-positive bacteria:Bacillus megaterium ATCC 14581 (IC50 = 2.25 μM, MIC = 5.00 μM), Staphylococcus aureus ATCC 6538 (IC50 = 0.63 μM, MIC = 10.0 μM), Enterococcus faecalis ATCC 29212 (IC50 = 0.66 μM, MIC = 5.00 μM);Gram-negative bacteria:Escherichia coli ATCC 700926 (IC50 = 38.3 μM, MIC > 20 μM);Fungi:Candida albicans 002 ATCC 64385 (IC50 > 20 μM, MIC > 20 μM), C. albicans 004 ATCC MYA-2876 (IC50 > 20 μM, MIC > 20 μM).",
            "Hemolytic Activity": "[Ref.28073163] HC50 = 13.4 μM against human red blood cells. Note:HC50 is the half-maximal hemolytic concentration.",
            "Cytotoxicity": "No cytotoxicity information found in the reference(s) presented",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Linear",
            "N-terminal Modification": "Acylation (Valerylamide)",
            "C-terminal Modification": "Amidation",
            "Stereochemistry": "L",
            "Structure Description": "Overall, the peptides showed some β-strand secondary structural characteristics and little α-helical content.",
            "Formula": "C₆₅H₁₀₃N₂₁O₁₁",
            "Mass": 1354.62,
            "PI": 12.3,
            "Net Charge": 3,
            "Hydrophobicity": -0.75,
            "Half Life": "Mammalian:2.8 hourYeast:3 minE.coli:2 min",
            "Function": "Antibacterial activity against Gram-positive and Gram-negative bacteria. Antifungal activity against Candida albicans is not noteable under 20 μM.",
            "Literature": [
                {
                    "Title": "Hydrocarbon-stapled lipopeptides exhibit selective antimicrobial activity",
                    "Pubmed ID": "28073163",
                    "Reference": "Biopolymers. 2017 May;108(3). doi 10.1002/bip.23006.",
                    "Author": "Zachary B Jenner, Christopher M Crittenden, Martín Gonzalez, Jennifer S Brodbelt, Kerry A Bruns",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=28073163"
                }
            ],
            "Frequent Amino Acids": "RAW",
            "Absent Amino Acids": "CDEFGHIKLMNOPQSTUY",
            "Basic Residues": 3,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 5,
            "Polar Residues": 6,
            "Positive Residues": 3,
            "Negative Residues": 0,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_13088",
                    "Similarity": 1.0,
                    "Sequence": "AAAALSRWWLRWWVA"
                },
                {
                    "SPADE_ID": "SPADE_N_13688",
                    "Similarity": 1.0,
                    "Sequence": "RRRWWWWV"
                },
                {
                    "SPADE_ID": "SPADE_UN_03035",
                    "Similarity": 1.0,
                    "Sequence": "KPQTRNWWV"
                }
            ]
        }
    }
}